Usefulness of detectable levels of troponin, below the 99th percentile of the normal range, as a clue to the presence of underlying coronary artery disease

被引:40
作者
Schulz, Olaf
Paul-Walter, Claudia
Lehmann, Matthias
Abraham, Klaus
Berghoefer, Gunnar
Schimke, Ingolf
Jaffe, Allan S. [1 ]
机构
[1] Mayo Clin & Mayo Grad Sch Med, Rochester, MN 55905 USA
[2] Univ Med Berlin Charite, Berlin, Germany
关键词
D O I
10.1016/j.amjcard.2007.03.096
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of the study was to evaluate whether markers of myocardial injury and ischemia are helpful in detecting coronary artery disease (CAD) in patients with stable angina. Venous blood was obtained before and after a bicycle exercise test in 47 outpatients with suspected CAD for measurement of cardiac troponin I (cTnI), heart-type fatty acid binding protein, and glycogen phosphorylase BB. Patients with a coronary artery stenosis >= 70% in diameter (n = 33) were compared with patients with coronary narrowing < 50% (controls, n = 14). None of the markers increased after bicycle exercise testing. cTnI measured before and after exercise was higher in the CAD group than in controls (p < 0.001). The area under the curve for diagnosis was greater when the cTnI value was detectable than with stress testing alone. In conclusion, baseline cTnI was of value in detecting CAD and also during follow-up in predicting the need for further revascularization. (C) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:766 / 771
页数:6
相关论文
共 29 条
[11]  
Krause EG, 1996, MOL CELL BIOCHEM, V161, P289
[12]   Elevated placental growth factor levels are associated with adverse outcomes at four-year follow-up in patients with acute coronary syndromes [J].
Lenderink, T ;
Heeschen, C ;
Fichtlscherer, S ;
Dimmeler, S ;
Hamm, CW ;
Zeiher, AM ;
Simoons, ML ;
Boersma, E .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (02) :307-311
[13]   Glycogen phosphorylase isoenzyme BB to diagnose ischaemic myocardial damage [J].
Mair, J .
CLINICA CHIMICA ACTA, 1998, 272 (01) :79-86
[14]  
MAYLAR N, 2001, EUR HEART J SUPPL, V522, pP2843
[15]   Cardiac troponin T levels for risk stratification in acute myocardial ischemia [J].
Ohman, EM ;
Armstrong, PW ;
Christenson, RH ;
Granger, CB ;
Katus, HA ;
Hamm, CW ;
OHanesian, MA ;
Wagner, GS ;
Kleiman, NS ;
Harrell, FE ;
Califf, RM ;
Topol, EJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (18) :1333-1341
[16]   Human heart-type cytoplasmic patty acid-binding protein (H-FABP) for the diagnosis of acute myocardial infarction. Clinical evaluation of H-FABP in comparison with myoglobin and creatine kinase isoenzyme MB [J].
Okamoto, F ;
Sohmiya, K ;
Ohkaru, Y ;
Kawamura, K ;
Asayama, K ;
Kimura, H ;
Nishimura, S ;
Ishii, H ;
Sunahara, N ;
Tanaka, T .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2000, 38 (03) :231-238
[17]   Evaluation of imprecision for cardiac troponin assays at low-range concentrations [J].
Panteghini, M ;
Pagani, F ;
Yeo, KTJ ;
Apple, FS ;
Christenson, RH ;
Dati, F ;
Mair, J ;
Ravkilde, J ;
Wu, AHB .
CLINICAL CHEMISTRY, 2004, 50 (02) :327-332
[18]   Glycogen phosphorylase BB in acute coronary syndromes [J].
Peetz, D ;
Post, F ;
Schinzel, H ;
Schweigert, R ;
Schollmayer, C ;
Steinbach, K ;
Dati, F ;
Noll, F ;
Lackner, KJ .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2005, 43 (12) :1351-1358
[19]  
RABITZSCH G, 1995, CLIN CHEM, V41, P966
[20]   Role of nondiagnostic exercise-induced ST-Segment abnormalities in predicting future coronary events in asymptomatic volunteers [J].
Rywik, TM ;
O'Connor, FC ;
Gittings, NS ;
Wright, JG ;
Khan, AA ;
Fleg, JL .
CIRCULATION, 2002, 106 (22) :2787-2792